Biomerica, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BMRA Nasdaq 3841 http://www.biomerica.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomerica, Inc.

Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. - Jun 5th, 2019 6:19 am
Could Biomerica, Inc.'s (NASDAQ:BMRA) Investor Composition Influence The Stock Price? - Apr 25th, 2019 8:06 am
BMRA: Revenue Slows Although Potential Growth Catalysts on the Horizon. Further Pipeline Progress - Apr 22nd, 2019 9:00 am
Biomerica Announces Third Quarter Financial Results - Apr 16th, 2019 7:18 am
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) - Apr 8th, 2019 6:19 am
LD Micro Virtual Conference Is Live, March 12th and 13th - Mar 12th, 2019 6:45 am
What You Must Know About Biomerica, Inc.’s (NASDAQ:BMRA) Beta Value - Feb 21st, 2019 12:49 pm
Biomerica Announces Updates for H. Pylori Clinical Studies - Feb 5th, 2019 6:19 am
An Intrinsic Calculation For Biomerica, Inc. (NASDAQ:BMRA) Shows It’s 32.14% Undervalued - Jan 22nd, 2019 12:42 pm
BMRA: Q2’19 Results: Asia Continues to Accelerate, Europe Rebounds, U.S. Still Weak But Could Return to Growth - Jan 21st, 2019 9:00 am
Biomerica Announces Second Quarter Financial Results - Jan 15th, 2019 6:19 am
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer - Nov 28th, 2018 6:19 am
Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications - Nov 16th, 2018 6:55 am
Can We See Significant Insider Ownership On The Biomerica Inc (NASDAQ:BMRA) Share Register? - Nov 16th, 2018 5:30 am
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud - Nov 7th, 2018 7:42 am
BMRA: Q1 2019: Asia Strong, Europe & U.S. Weak. Revenue up 13% QoQ But Down 12% yoy. Expense Control Minimizes Op Loss. - Oct 22nd, 2018 11:15 am
Is Biomerica Inc (NASDAQ:BMRA) A Financially Sound Company? - Sep 26th, 2018 10:00 am
BMRA: Legacy Biz Slows in Q4. Operational Highlights Include InFoods Enrolling, Ex-Walgreens CMO Joins SAB (and we’re intrigued) - Sep 7th, 2018 8:00 am